Table 1 Patient characteristics
Hong Kong | Bangkok, Thailand | Chiang Mai, Thailand | Manila, Philippines | ||||
|---|---|---|---|---|---|---|---|
Total = 88 (%) | Total = 277 (%) | Total = 17 (%) | Total = 69 (%) | ||||
Without TDRM = 85 (96.6) | With TDRM = 3 (3.4) | Without TDRM = 264 (95.3) | With TDRM = 13 (4.7) | Without TDRM = 17 (100.0) | Without TDRM = 63 (91.3) | With TDRM = 6 (8.7) | |
Age (years) | Median = 29 | Median = 42 | Median = 23 | Median = 23 | Median = 22 | Median = 25 | Median = 30.5 |
IQR (24–37) | IQR (32–56) | IQR (21–24) | IQR (20–25) | IQR (21–23) | IQR (23–28) | IQR (25–33) | |
<25 | 25 (29.4) | 0 (0.0) | 207 (78.4) | 9 (69.2) | 17 (100.0) | 28 (44.4) | 1 (16.7) |
25-34 | 30 (35.3) | 1 (33.3) | 47 (17.8) | 4 (30.8) | 0 (0.0) | 34 (54.0) | 4 (66.7) |
35-44 | 21 (24.7) | 1 (33.3) | 7 (2.7) | 0 (0.0) | 0 (0.0) | 1 (1.6) | 1 (16.7) |
≥45 | 9 (10.6) | 1 (33.3) | 3 (1.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Sex | |||||||
Male | 81 (95.3) | 3 (100.0) | 247 (93.6) | 13 (100.0) | 12 (70.6) | 54 (85.7) | 5 (83.3) |
Female | 4 (4.7) | 0 (0.0) | 17 (6.4) | 0 (0.0) | 5 (29.4) | 9 (14.3) | 1 (16.7) |
HIV exposure | |||||||
Heterosexual contact | 9 (10.6) | 0 (0.0) | 30 (11.4) | 1 (7.7) | 10 (58.8) | 9 (14.3) | 1 (16.7) |
Homosexual contact | 72 (84.7) | 3 (100.0) | 229 (86.7) | 11 (84.6) | 7 (41.2) | 39 (61.9) | 3 (50.0) |
Bisexual | 4 (4.7) | 0 (0.0) | 4 (1.5) | 1 (7.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Injecting drug use | 0 (0.0) | 0 (0.0) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Other/Unknown | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (3.2) | 0 (0.0) |
Viral load (copies/ml) | Median = 77000 | Median = 46000 | Median = 41790 | Median = 170000 | Median = 75001 | N/A | N/A |
IQR (20261–220000) | IQR (59000–68000) | IQR (16208–130000) | IQR (17414–360000) | IQR (39375–80119) | |||
≤50000 | 36 (42.4) | 2 (66.7) | 144 (54.5) | 6 (46.2) | 7 (41.2) | 0 (0.0) | 0 (0.0) |
50001-250000 | 28 (32.9) | 1 (33.3) | 84 (31.8) | 1 (7.7) | 10 (58.8) | 0 (0.0) | 0 (0.0) |
250001+ | 21 (24.7) | 0 (0.0) | 35 (13.3) | 6 (46.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Missing | 0 (0.0) | 0 (0.0) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 63 (100.0) | 6 (100.0) |
CD4 (cells/uL) | Median = 408.5 | Median = 348 | Median = 342 | Median = 370.5 | Median = 308 | N/A | N/A |
IQR (267–552) | IQR (315–641) | IQR (255–479) | IQR (271–438) | IQR (103–405.5) | |||
≤50 | 4 (4.7) | 0 (0.0) | 5 (1.9) | 0 (0.0) | 4 (23.5) | 0 (0.0) | 0 (0.0) |
51-100 | 1 (1.2) | 0 (0.0) | 6 (2.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
101-200 | 4 (4.7) | 0 (0.0) | 20 (7.6) | 1 (7.7) | 1 (5.9) | 0 (0.0) | 0 (0.0) |
201-500 | 44 (51.8) | 2 (66.7) | 128 (48.5) | 8 (61.5) | 10 (58.8) | 0 (0.0) | 0 (0.0) |
>500 | 25 (29.4) | 1 (33.3) | 46 (17.4) | 1 (7.7) | 1 (5.9) | 0 (0.0) | 0 (0.0) |
Missing | 7 (8.2) | 0 (0.0) | 59 (22.3) | 3 (23.1) | 1 (5.9) | 63 (100.0) | 6 (100.0) |
Subtype | |||||||
CRF01_AE | 24 (28.2) | 0 (0.0) | 218 (82.6) | 11 (84.6) | 14 (82.4) | 22 (34.9) | 2 (33.3) |
B | 52 (61.2) | 3 (100.0) | 22 (8.3) | 1 (7.7) | 2 (11.8) | 24 (38.1) | 3 (50.0) |
Other | 9 (10.6) | 0 (0.0) | 24 (9.1) | 1 (7.7) | 1 (5.9) | 17 (27.0) | 1 (16.7) |